The Munich-based medical technology start-up iThera Medical GmbH raised 7 million euros in mid-September. The capital will be used chiefly to finance clinical studies.

BioNTech AG has forged another top-class alliance with a large pharmaceutical company: together with Pfizer, the Mainz-based company plans to develop novel flu vaccines.

After successful funding, the start-up company Purenum has started its work. The aim is to further develop the biocompatible medical adhesive developed in the GO-Bio project mediNik.

The Pro-Detekt research group based at the Life Science Incubator (LSI) in Saxony was able to extend its patent protection for the key PRET-ELISA technology to the USA.

The GO-Bio winners for 2018 have been named: Eight start-up teams took home awards from the biotechnology conference in Berlin. They will each receive funding running into millions of euros from the BMBF.

The biotech sector is in a record-breaking mood: In 2017, more capital was raised than ever before.

BioNTech AG, which emerged from a GO-Bio grant, announced at the beginning of January the conclusion of a series A financing round amounting to 225 million euros.

The protein analysis start-up Dynamic Biosensors in Martinsried (Germany) has acquired series B financing of 5 million Euros venture capital. New investor: BayBG.

Researchers of the Forschungszentrum Jülich enter the second GO-Bio phase with their start-up ‘SenseUp’: The special technology can locate highly productive bacteria for biotech applications.

The spin-off by the Karlsruhe Institute for Technology received a grant of 1.75 million Euros for the advancement of cancer medication.

The Bonn-based spin-off Rigontec specialises in RNA therapies to stimulate the immune system. Now Merck & Co wants to take over the company for as much as 464 million Euros.

The Munich-based GO-Bio start-up company Ethris has started a five-year cooperation with AstraZeneca to further develop mRNA therapies, receiving an advance payment of 25 million Euros in the process.

The High-Tech Gründerfonds is investing in the Reutlingen-based GO-Bio start-up Signatope for the development of a new biomarker test procedure for drug development.

Life sciences researchers who want to start a business can apply for the BMBF competition GO-Bio with their project ideas. Millions in funding awaits.